Baxter Declares Quarterly Dividend
DEERFIELD, Ill. -- February 19, 2013
The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared
a quarterly dividend of $0.45 per Baxter common share. The dividend is payable
on April 1, 2013 to shareholders of record as of March 8, 2013.
Baxter continues to generate strong cash flow and has returned significant
value to shareholders in the form of dividends and share repurchases. In 2012,
Baxter returned approximately $2.3 billion to shareholders through dividends
totaling $800 million and share repurchases of approximately $1.5 billion (or
approximately 25 million shares).
Baxter International Inc., through its subsidiaries, develops, manufactures
and markets products that save and sustain the lives of people with
hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and
other chronic and acute medical conditions. As a global, diversified
healthcare company, Baxter applies a unique combination of expertise in
medical devices, pharmaceuticals and biotechnology to create products that
advance patient care worldwide.
This release includes forward-looking statements concerning the company's
dividend. The statements are based on assumptions about many important
factors, including the following, which could cause actual results to differ
materially from those in the forward-looking statements: continued strength in
the company’s financial position, including cash flows; future decisions of
the board of directors of the company to continue payments to shareholders in
the form of a dividend on a quarterly or other basis relative to alternative
uses of funds; and other risks identified in the company's most recent filing
on Form 10-K and other SEC filings, all of which are available on the
company's website. The company does not undertake to update its
Baxter International Inc.
Deborah Spak, (224) 948-2349
Mary Kay Ladone, (224) 948-3371
Clare Trachtman, (224) 948-3085
Press spacebar to pause and continue. Press esc to stop.